Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-07-25
2006-07-25
Wang, Sheng Jun (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S389000, C514S391000, C514S394000, C514S622000, C514S709000, C514S708000
Reexamination Certificate
active
07081469
ABSTRACT:
Vascular damaging agents composed of substituted 5(6)-substituted benzimidazole-2-carbamates are provided. These agents are useful in the preparation of medicaments for the treatment of diseases involving neovascularisation, particularly for the treatment of solid tumors, macular degeneration, diabetic retinopathy, rheumatoid arthritis, psoriasis, and atherosclerosis. Embodiments include a 5(6)-substituted benzimidazole-2-carbamate of formula Iwherein A represents a multi-substituted alkyl group or aromatic ring.
REFERENCES:
patent: 3694455 (1972-09-01), Dunn
patent: 3928375 (1975-12-01), Diiwel et al.
patent: 3965113 (1976-06-01), Beard et al.
patent: 3984561 (1976-10-01), Loewe et al.
patent: 5763473 (1998-06-01), Elokdah et al.
patent: 2164690 (1973-07-01), None
patent: 2332343 (1975-01-01), None
Nare et al. Biochemical Pharmacology (1994), 48(12), 2215-22.
Kruse, L.I., et al., “Synthesis, Tubulin Binding, Antineoplastic evaluation, and Structure-Actvity Relationship of Oncodazole Analogues,” Journal of Medicinal Chemistry,, vol. 32, No. 2, Feb. 1989, pp. 409-417,XP002142971.
Lacey, E., et al., “Activity of Benzimidazole Carbamates Against L1210 mouse Leukaemia cells: Correlation with in Vitro Tubulin Polymerization assay,” Biochemical Pharmacology, vol. 34, No. 19, 1985, pp. 3603-3605, XP002056333.
Chemical Abstract of de Brabander, M.J., et al., “The effects of methyl5-(2-thienylcarbonyl)-1H-benzimidazol-2-yl Carbamate. (R 17934: NSC 238159), a new synthetic antitumoral drug interfering with microtubles, on mammalian cells cultured in vitro,” p. 26; XP002143095, cited in the application abstract & Cancer Res., vol. 36, No. 3, 1976, pp. 905-916, Chemical Abstract, vol. 84, No. 21.
Khan, A.M. et al., “Studies on enteric anthelmintics: Impact of single point structural change on the activity profile,” Zeitschrift Fur Naturfoschung, B, vol. 43, No. 2, Feb. 1988, pp. 233-237.
Raeymaekers, A.H.M., et al., “Synthesis and Anthelmintic Activity of Alkyl-(5-acyl-1H-benzimidazol-2yl) carbamates,” Arzneimittel-Forschung, vol. 28 (I), No. 4, 1978, pp. 586-594, XP002142973.
Abuzar, S., et al., “Synthesis and anthelmintic activity of 2,2′-disubstitued 5,5-dibenzimidazolylsufides and sulfones,” Arzeimittel-forschung, vol. 36 (I), No. 3, Mar. 1986, pp. 416-419, XP002142974.
Database Crossfire “Online”, Beilstein Institut zur Foerderung der Chemischen Wissenschaften; XP 002142975, Beilstein Registry No. 4595458 & Indian J. Chem. Sect. B, vol. 19, No. 7, 1980, pp. 536-538.
Database Crossfire “Online” Beilstein Institut zur Foerderung der Chemischen Wissenschaften; XP 002142976, Beilstein Registry No. 5651135 & Indian J Chem. Sect. B, vol. 24, 1985, pp. 754-760.
Database Crossfire “Online” Beilstein Institut zur Foerderung der Chemischen Wissenschaften; XP002142977, Beilstein Registry No. 5622648 & Indian J. Chem. Sect. B, vol. 24, 1985, pp. 747-753.
Database Crossfire “Online” Beilstein Institut zur Foerderung der Chemischen Wissenschaften; XP 002142978, Beilstein Registry No. 5669479, 5670801, 5667941, 5667940, 5665325 & Indian J. Chem. Sect. B, vol. 24, 1985, pp. 730-732.
Database Crossfire “Online” Beilstein Institut zur Foerderung der Chemischen Wissenschaften; XP 002142978, Beilstein Registry No. 4615289, 4609187, & Indian J. Chem. Sect. B, vol. 23, No. 12, 1984, pp. 1274-1278.
Database Crossfire “Online” Beilstein Institut zur Foerderung der Chemischen Wissenschaften; XP 002142980, Beilstein Registry No. 6009722, 6007941, 6007769 & Indian J. Chem. Sect. B, vol. 24, 1985, pp. 178-181.
Angiogene Pharmaceuticals Ltd.
Foley & Lardner LLP
Kim Jennifer
Mulkeen Matthew E.
Villacorta Gilberto M.
LandOfFree
Benzimidazole vascular damaging agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzimidazole vascular damaging agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimidazole vascular damaging agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3610263